World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 7 November 2022
Main ID:  NCT03497481
Date of registration: 06/04/2018
Prospective Registration: Yes
Primary sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Public title: Neopterin Dosage in the Eye CHA
Scientific title: Appreciation of the Possibility of Dosing Neopterin in Eye Liquids. Pilot Study of Neopterin Dosage in Eye Liquids.
Date of first enrolment: June 22, 2018
Target sample size: 20
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03497481
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
France
Contacts
Name:     AnĂ©lia Benarrosh, doctor
Address: 
Telephone:
Email:
Affiliation:  Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Name:     Chaker Nefzaoui, doctor
Address: 
Telephone:
Email:
Affiliation:  Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age = 18 years-old

- Non inflammatory or non infectious ophthalmic pathology requiring puncture of eye's
anterior chamber fluid.

- Minimum of 200 microliter sample

- Immunocompetent subjects

- Signed and dated informed consent

- Samples management in accordance with the pre-analytical conditions specified in the
protocol

Non-inclusion criteria:

- Age < 18 years-old

- Subjects treated with intraocular corticoids, antibiotics or anti-inflammatory,
locally or in systemic injection, prior to inclusion.

Exclusion Criteria:

- Subjects who exercised his right of withdrawal

- Study suspended on principal investigator, sponsor or health authorities' demand.

- Deceased subjects



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Cataract
Intervention(s)
Biological: Samples
Primary Outcome(s)
Detection and dosage of neopterin in the eye [Time Frame: 3 month]
Secondary Outcome(s)
False positives identification and elimination. [Time Frame: 3 month]
Neopterin concentration comparison between study values and reference value. [Time Frame: 3 month]
Secondary ID(s)
2017-A00183-47
2017-CHITS-02
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Hospices Civils de Lyon
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history